Table 2.
Multivariate analysis of the impact of variables on overall survival (OS) and distant progression-free survival (DPFS) in esophageal squamous cell carcinoma (ESCC) patients
| Variable | OS | DPFS | ||
|---|---|---|---|---|
|
| ||||
| HR (95% CI) | P | HR (95% CI) | P | |
| TNM stage | 5.26 (1.02-10.63) | 0.01 | 5.12 (1.00-10.58) | 0.01 |
| Tumor differentiation | 3.92 (0.63-7.86) | 0.03 | 3.86 (0.60-7.69) | 0.03 |
| Lymphatic metastasis | 3.51 (0.58-7.26) | 0.03 | 3.48 (0.50-7.18) | 0.03 |
| miR-195 expression | 5.96 (1.26-11.93) | 0.01 | 5.59 (1.13-11.16) | 0.01 |
| Cdc42 expression | 5.33 (1.11-11.08) | 0.01 | 5.18 (1.05-11.02) | 0.01 |
| miR-195/Cdc42 expression | 6.89 (1.66-14.19) | 0.001 | 6.69 (1.58-13.99) | 0.01 |